TZT improves endothelial dysfunction (ED) and associated inflammatory changes through modulation of glucose homeostasis, insulin sensitivity, and pro-inflammatory biomarkers release
L cell secretagogues Stimulation of GLP-1 secretion from enteroendocrine L cells is another approach that may be able to realise the therapeutic potential of GLP-1, perhaps in combination with DPP-4 inhibition to prevent the inactivation of the GLP-1 released
Step 5: Clarify Logistics and Administration Explain the practical aspects of therapy, including timing, routine integration, and access
In a recent study published in The New England Journal of Medicine, the pill lowered blood sugar levels and weight in people with type 2 diabetes
Sex-specific increases in subcutaneous and visceral fat in response to the WD Both sexes gained subcutaneous fat (IWAT) on a WD, but only females on the WD gained visceral fat (GWAT)
Ozempic was approved by the Food and Drug Administration for treating type 2 diabetes